baber/WOPTO huggingface dataset:
Patent BR-PI0807734-B1 (BR)
Title: Processo para tratar lama e fabricar fertilizante inorgânico contendo nitrogênio altamente enriquecido bioorganicamente
Inventor: GARY DAHMS
IPC: C05D9/02
Filed: 2008-02-19
Abstract: processo para tratar lama e fabricar fertilizante inorgânico contendo nitrogênio altamente enriquecido bioorganicamente a invenção descreve um método para tratar a lama para produzir fertilizante inorgânico organicamente enriquecido com alto teor de nitrogênio que pode competir com o tradicional. o método envolve condicionar biosólidos secos ou lama orgânica, e efeitos odorizantes interagida com os tratar com um oxidante para reduzir e um ácido. esta mistura é então ácidos sulfúrico ou fosfórico concentrados e uma fonte de amônia ou alternativamente uma fusão à quente ou sal quente de sulfato/fosfato de amônio para formar uma mistura de fertilizante sob temperatura, pressão e tempos de retenção controlados. esta invenção pode também ser um adicional à produção comercial de sais de amônio. o fertilizante produzido pela presente invenção contém mais de 8% de peso de nitrogênio e preferivelmente 15% de peso de nitrogênio. a invenção é ajustada para a produção de biosólidos em estações de tratamento de resíduo municipal individual mantendo as estações de fabricação de fertilizante da presente invenção pequenas com uma minimização de logística e responsabilidade.
Patent BR-PI0820923-B1 (BR)
Title: Método para produção de masterbatch de borracha natural, masterbatch de borracha natural, composição de borracha, e pneu
Inventor: ATSUSHI NAKAYAMA
IPC: C08J3/22
Filed: 2008-11-25
Abstract: ”método para produção de masterbatch de borracha natural, masterbatch de borracha natural, composição de borracha, e pneu” a presente invenção se refere a um método de produção de um masterbatch de borracha natural, que compreende uma etapa de misturar um látex de borracha natural e uma pasta de dispersão aquosa, na qual um negro de fumo está disperso. neste método, a quantidade do negro de fumo misturado está na faixa de 10 a 100 partes, em massa, com base em 100 partes, em massa, de um componente de borracha natural no látex de borracha natural; e o negro de fumo atende às relações expressas por (1) 120 < área superficial específica de adsorção ctab < 160, (2) 50 < 24m4dbp < 100, e (3) 75 < transmitância de descoloração de tolueno (%) < 95. também são descritos um masterbatch de borracha natural obtido pelo presente método de produção, uma composição de borracha utilizando o presente masterbatch de borracha natural, e um pneu utilizando a presente composição de borracha.
Patent BR-PI0822922-B1 (BR)
Title: Variador planetário, transmissão variável e reversível e uso dos mesmos
Inventor: FILIP DE MAZIERE
IPC: F16H15/38
Filed: 2008-06-05
Abstract: transmissão variável e reversível- rvt a presente invenção refere-se a um novo tipo de transmissão variável e reversível para veículos, tais como carros, ônibus, caminhões, veículos fora de estrada, empilhadeiras, manipuladores de lança telescópica e similares. alternativamente, a caixa de câmbio pode ser usada em sistemas, tais como moinhos de vento, etc., e em outras aplicações industriais em que é exigida a transferência de potência em velocidades variáveis.
Patent BR-PI0900723-B1 (BR)
Title: Composição oftálmica tópica para tratar ou prevenir infecções oftálmicas bacterianas em um paciente humano
Inventor: KOTHANDA RAMAN THYAGA RAJAN
IPC: A61K31/4709
Filed: 2009-03-10
Abstract: SUSPENSÃO OFTÁLMICA PARA USO OCULAR. A presente invenção refere-se a composições farmacêuticas oftálmicas tópicas de gatifloxacina e prednisolona para a prevenção e tratamento de infecções bacterianas oftálmicas e condições inflamatórias associadas e cirurgias oculares pré-cirúrgicas ou pós-cirúrgicas.
Patent BR-PI0910102-B1 (BR)
Title: Métodos e aparelho para balanceamento dinâmico de carga com e-aich
Inventor: AZIZ GHOLMIEH
IPC: H04W74/08
Filed: 2009-03-30
Abstract: métodos e aparelho para balanceamento dinâmico de carga com e-aich são descritos sistemas e metodologias que facilitam o balanceamento de carga dinâmico em uma rede de comunicações. em particular, um ou mais dispositivos móveis podem enviar os preâmbulos de acesso aleatório sobre uma frequência uplink combinada com. uma frequência downlink empregada para conectar o um ou mais dispositivos móveis a uma estação base. a estação base pode determinar se existe um desbalanceamento de carga de frequência uplink baseado nos preâmbulos de acesso aleatório. a estação base pode transmitir um indicador em um canal de indicador de aquisição para pelo menos um dispositivo móvel sendo que o indicador inclui um comando para transição para uma nova frequência uplink. o dispositivo móvel pode comutar frequências uplink em resposta ao comando.
Patent BR-PI0918667-B1 (BR)
Title: sistema de engates de vagão ferroviário e método
Inventor: GEORGE S CREIGHTON
IPC: B61G3/00
Filed: 2009-09-17
Abstract: sistema de engates de vagão ferroviário e método um engate de vagão ferroviário inclui uma porção de cabeça de engates estendendo-se a partir de uma porção de haste. a porção de cabeça de engates é configurada para se acoplar a uma primeira mandíbula de engates para acoplar o engate de vagão ferroviário a um segundo engate de vagão ferroviário de um vagão ferroviário adjacente. a porção de cabeça de engates compreende uma porção de nariz e uma face de encontro estendendo-se a partir da porção de nariz para acoplar uma segunda mandíbula de engates acoplada ao segundo engate de vagão ferroviário. a porção de cabeça de engates compreende uma porção de braço de proteção estendendo-se a partir da porção de nariz em direção à porção de haste. a porção de cabeça de engates compreende uma porção de alavanca tendo uma superfície traseira. a distância entre a superfície traseira da porção de alavanca e uma extremidade de nariz da porção de braço de proteção é de menos de 11 polegadas. a porção de cabeça de engates compreende uma plataforma de levantador de castanha com menos que 2 polegadas acima de uma borda de fundo do engate.
Patent BR-PI0923624-B1 (BR)
Title: Palmilha para aliviar a dor da artrite
Inventor: CHARLES E LUNDY JR
IPC: A61F5/01
Filed: 2009-12-18
Abstract: palmilha, e, métodos para montar uma palmilha, e para aliviar dor de artrite. é divulgada uma palmilha (1) de calçado adaptada para aliviar a dor de artrite do pé, joelho e/ou quadril pela provisão de uma camada de invólucro rígido (4) para suporte de arco, e de uma lona de topo (2), uma camada de amortecimento superior (3) e uma camada de amortecimento inferior (5) para amortecimento. adicionalmente, a camada de invólucro rígido inclui uma abertura do invólucro (13) e a camada de amortecimento inferior inclui uma abertura da camada inferior (14), através da qual uma parte da camada de amortecimento superior se estende para amortecimento.
Patent EA-004232-B1 (EA)
Title: Novel pharmaceutical preparation
Inventor: BLACKLER PAUL DAVID JAMES
IPC: A61K31/00
Filed: 2000-04-19
Abstract: 1. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, hydrochloride dihydrate characterized in that it: (i) provides an infrared spectrum containing peaks at 3392, 2739, 1751, 1325 and 713 cm<-1>; and/or (ii) provides an X-ray powder diffraction (XRPD) pattern containing peaks at 9.1, 12.0, 15.7, 16.3 and 19.8 degree 2theta. 2. A hydrate according to claim 1, which provides an infrared spectrum substantially in accordance with Figure I. 3. A hydrate according to claim 1 or claim 2, which provides an X-ray powder diffraction (XRPD) pattern substantially in accordance with Figure II. 4. A hydrate according to any one of claims 1 to 3, in isolated form. 5. A hydrate according to any one of claims 1 to 4, in pure form. 6. A process for preparing a hydrate according to claim 1, characterized in that 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (Compound I) is treated with a suitable source of hydrochloride counter-ion and an appropriate amount of water for formation of the Hydrochloride Hydrate; and thereafter the required compound is recovered. 7. A pharmaceutical composition comprising an effective, non-toxic amount of a hydrate according to claim 1 and a pharmaceutically acceptable carrier therefor. 8. A hydrate according to claim 1, for use as an active therapeutic substance. 9. A hydrate according to claim 1, for use in the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof. 10. The use of hydrate for the manufacture of a medicament for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof. 11. A method for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof, in a human or non-human mammal, which comprises administering an effective, non-toxic, amount of hydrate to a human or non-human mammal in need thereof.
Patent EA-002641-B1 (EA)
Title: Method for producing components for engine fuels
Inventor: LIKHOLOBOV VLADIMIR ALEXANDROV
IPC: C10G69/08
Filed: 2000-04-24
Abstract: 1. A method for producing components for engine fuels, comprising reforming in the presence of platinum-containing catalyst with a subsequent separation of liquid high-octane products from gaseous products (hydrogen and C1-C4 hydrocarbon gases) and recycling C1-C4 hydrocarbon gases into the reforming area, characterized in that the gaseous products of reforming are subjected to separating by binding hydrocarbon at contacting with aromatic hydrocarbons in the area of catalytic hydrogenation, after which the products of hydrogenation are separated and C1-C4 hydrocarbon gases are recycled into the reforming area. 2. The method according to claim 1, characterized in that C1-C4 hydrocarbon gases are continuously recycled in a closed area from the hydrogenation area to the reforming area and back, keeping them in the process. 3. The method according to claim 2, characterized in that an additional amount of C1-C4 hydrocarbon gases is supplied into the recycling gas flow from an outer source. 4. The method according to claim 1, characterized in that speed of hydrogen binding in the hydrogenation is maintained being equal to the speed of hydrogen separation in the reforming area. 5. The method according to claim 1, characterized in that the process in the hydrogenation is performed at a pressure being not less than 0.3 MPa and at a temperature 50-300 degree C using a catalyst comprising VIII group metal(s). 6. The method according to claim 1, characterized in that the hydrogenation products are separated to cyclohexane-type hydrocarbons and C1-C4 hydrocarbon gases by a method of medium-temperature phase separating. 7. The method according to claim 1, characterized in that the bound hydrogen is removed from the process in the form of the cyclohexane-type hydrocarbons. 8. The method according to claim 1, characterized in that the cyclohexane-type hydrocarbons are directed into the area of catalytic dehydrogenation with a subsequent separation of the dehydrogenation products to aromatic hydrocarbons, which are recycled into the hydrogenation area, and hydrogen. 9. The method according to claim 8, characterized in that the process in the hydrogenation is performed at a temperature 300-500 degree C using a catalyst comprising VIII group metal(s). 10. The method according to claim 1, characterized in that C1-C4 hydrocarbon dissolved in liquid products are separated and then recycled into reforming area for mixing liquid raw material. 11. The method according to claim 1, characterized in that C1-C4 hydrocarbon dissolved in the cyclohexane-type hydrocarbons products are separated and then recycled into reforming area for mixing liquid raw material. 12. The method according to claim 1, characterized in that the reforming area comprises one reactor or a system of several reactors.
Patent EA-006194-B1 (EA)
Title: Method for producing fullerenes and device therefor
Inventor: BORESENKO ALEXANDER VASILIEVICH
IPC: B01J19/08
Filed: 2004-11-30
Abstract: The invention relates to physicochemical processes of fullerenes production by processing gaseous carbon-containing material. The technical result - less power consumption caused by not using graphite electrodes and using instead production wastes as an initial material, simplification of the method and the device design for fullerene production, flue gas cleaning from poisons and avoiding pollution of environment are achieved using the method of fullerenes production which includes carbon-containing material treatment under high electric intensity and according to the invention carbon-containing gas is used as carbon-containing material which is passed between a fluid grounded precipitating electrode formed by water stream, and an electrode consisting from, at least, one needle and connected to a 10-3000 kV power source for creating unipolar ionization and generating atomic hydrocarbon used to reduce hydrocarbon and collect it on the fluid grounded precipitating electrode as fullerenes. According to the invention in the device for fullerenes production which comprises a reaction chamber with electrodes one of them is connected to a high-voltage power source and consists of, at least, one needle, wherein the other electrode if formed by grounded water stream and serves as a precipitating electrode for fullerenes precipitation.
Patent EA-010409-B1 (EA)
Title: A use of dextran sulfate for inhibiting instant blood-mediated inflammatory reaction
Inventor: NILSSON BO
IPC: A61K/
Filed: 2003-11-26
Abstract: The present invention refers to use of dextran sulfate, or a pharmaceutically acceptable derivate thereof, for manufacturing of a medicament for treatment of Instant Blood-Mediated Inflammatory Reaction (IBMIR). In addition, the invention refers to the use of dextran sulfate, or a pharmaceutically acceptable derivate thereof, for manufacturing of a medicament for treatment of morphological disruption of cell transplants and graft-rejection of cell transplants caused by IBMIR. The invention may be applied to patients suffering from type I diabetes, in which porcine islets of Langerhans are transplanted in their portal vein. Administration of dextran sulfate according to the invention inhibits and prevents rejection and destruction of the transplanted islets and makes normoglycemia in the patients possible.
Patent EA-015114-B1 (EA)
Title: Radiation image conversion panel and radiation image sensor
Inventor: OHBAYASHI YASUSHI
IPC: G21K4/00
Filed: 2008-06-11
Abstract: For a radiation image converting panel according to the present invention, a converting portion that converts a radiation image to an optical image is formed on a support for which a dielectric multilayer film is formed on a metal reflector, and the dielectric multilayer film includes at least a first dielectric layer that is in contact with the metal reflector and a second dielectric layer that is formed on the first dielectric layer and has a higher refractive index than that of the first dielectric film layer to light emitted by the converting portion.
Patent EA-016110-B1 (EA)
Title: Wc bowl and mounting base
Inventor: OLLILA MATTI
IPC: E03D11/16
Filed: 2008-05-28
Abstract: The invention relates to WC bowl comprising a frame portion (1) whose lower surface (2) is intended to be mounted at least partially on a mounting foundation, such as a floor, the WC bowl comprises one or more mounting bases (5) with one or more holes therein and at least two support elements (53), each of them has a support surface (51) for contact and holding WC bowl on the mounting surface, wherein the support elements (53) are mounted in the threaded holes of the mounting bases (5) for adjusting the distance between the lower surface (2) and the mounting surface and putting the WC bowl in a horizontal plane, wherein the mounting base (5) is arranged in the frame portion (1) and fastened to the inner wall of the WC bowl constituting sais frame portion, or to the lower frame surface.
Patent EA-020889-B1 (EA)
Title: Cartridge, pharmaceutical dispenser for solid pharmaceutical portions and applications of said cartridge and said pharmaceutical dispenser
Inventor: LEIFELD SABINE
IPC: B65D83/04
Filed: 2009-11-14
Abstract: For safe storage and simple and safe administration of tablets (T) by a user, a cartridge (900) is provided that can be inserted into a pharmaceutical dispenser (1) for solid pharmaceutical portions (T) and that is designed with a reservoir for receiving the pharmaceutical portions (T), and a pharmaceutical dispenser (1) for this cartridge (900) is also provided. According to the invention, the cartridge (900) comprises a singulation device (910) that is designed to dispense defined pharmaceutical portions (T) and that comprises a movable mechanism (940) for separating a defined pharmaceutical portion (T) from the reservoir and for dispensing it from the pharmaceutical dispenser (1), wherein the singulation device (910) is designed to produce an operative connection to an actuating device (14, 220, 224, 226; 15, 210; 230) in the pharmaceutical dispenser (1). The proposed inventive cartridge is designed so that defined pharmaceutical portions (T) when separating them and dispensing them from the dispenser (1) have no contact with the dispenser (1).
Patent EA-021367-B1 (EA)
Title: Pyridine-3-carboxyamide derivative
Inventor: KITAMURA TAKAHIRO
IPC: C07D417/12
Filed: 2009-11-27
Abstract: Provided is a novel JAK3 inhibitor useful as a preventive and/or therapeutic agent for preventing and/or treating rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjogren's syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic conjunctivitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia, etc. A pyridine-3-carboxyamide derivative represented by general formula (1)or a salt thereof or a solvate thereof.
Patent EA-021074-B1 (EA)
Title: Process for the preparation of sevelamer hydrochloride and sevelamer carbonate/bicarbonate
Inventor: VILLANI FLAVIO
IPC: C08J3/24
Filed: 2010-05-10
Abstract: The present invention relates to a process for the preparation of sevelamer, described by formula (I), where a+b=9, c=1, and m is a variable, in particular sevelamer hydrochloride and sevelamer carbonate/bicarbonate, by means of a process that allows sevelamer to be obtained with good yields and using conventional reactors, without requiring to use specific and expensive equipment.
Patent EA-019552-B1 (EA)
Title: Polymer composition and molded article for lab/medical devices
Inventor: LOPEZ MARGARITO
IPC: B32B27/16
Filed: 2009-10-20
Abstract: Polymer compositions and articles formed therefrom are described herein. The compositions include a random copolymer and a radiation additive, wherein the random copolymer includes propylene and less than 2 wt.% ethylene and exhibits a melt flow rate of from about 300 to 100 dg/min., the polymer composition exhibits a flexural modulus of from about 1.1 MPa (160 kpsi) to about 1.38 MPa (200 kpsi) and the polymer composition is adapted to produce a polymer article exhibiting low plate out, a haze at 0,508 mm of no greater than 15%, radiation stability and autoclavability.
Patent EA-028409-B1 (EA)
Title: Automated drilling fluid analyzer
Inventor: STOCK TORE
IPC: G01N33/18
Filed: 2011-02-10
Abstract: An automatic drilling fluid property analyzer including a housing having an inlet and an outlet; at least one valve disposed proximate the inlet and configured to open and close to provide a sample of fluid into the housing; an electronic control module configured to send a signal to the at least one valve; a probe assembly operatively coupled to the electronic control module, the probe assembly including an electrode probe having two electrodes and a probe gap therebetween; a viscometer sleeve disposed in the housing; a bob disposed in the sleeve, wherein an annulus is formed between the viscometer sleeve and the bob, and wherein at least one of the viscometer sleeve and the bob is configured to rotate, a motor operatively coupled to at least one of the viscometer sleeve and the bob; and a torque measuring device operatively coupled to the viscometer sleeve and the bob.
Patent EA-023320-B1 (EA)
Title: Method and system of rendering well log values
Inventor: LIN CHING-RONG
IPC: G06T17/05
Filed: 2010-05-27
Abstract: Rendering well log values. At least some of the illustrative embodiments are methods that involve sending to a graphics processing unit (GPU) of a computer system vertices that define a panel, the sending by a main processor of the computer system, the main processor distinct from the GPU; sending a program to the GPU, the sending of the program by the main processor; sending a first set of well log values to the GPU, the sending of the first set of well log values by the main processor; executing the program by the GPU which program determines a first curve from the first set of well log values by the program executed by the GPU; and displaying on a display device of the computer system the first curve within the panel.
Patent EA-024350-B1 (EA)
Title: Pyrrolotriazinone derivatives as pi3k inhibitors
Inventor: BERNAL ANCHUELA FRANCISCO JAVIER
IPC: C07D487/04
Filed: 2012-04-26
Abstract: New pyrrolotriazinone derivatives having the chemical structure of formula (Iare disclosed, as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
Patent EA-024507-B1 (EA)
Title: Highly soluble leptins
Inventor: ERICKSON MARY
IPC: C07K14/575
Filed: 2011-09-28
Abstract: The disclosure provides chimeric polypeptides and nucleic acid molecules encoding chimeric polypeptides. Also provided are pharmaceutical compositions and methods of treatment for diseases and disorders including lipodystrophy, dyslipidemia, hyperlipidemia, overweight, obesity, hypothalamic amenorrhea, Alzheimer's disease, leptin deficiency, fatty liver disease or diabetes (including type I and type II). Additional diseases and disorders which can be treated by the compounds and methods described herein include nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD), metabolic syndrome X and Huntington's Disease.
Patent EA-023066-B1 (EA)
Title: Method for production of resin-free naftalan oil
Inventor: ZAMANOV VOLODYA NADIR OGLY
IPC: C10G25/06
Filed: 2014-04-21
Abstract: The invention relates to petrochemistry, in particular, to production of resin-free naftalan oil, and can be used for treatment of dermal, neurological, surgical, gynaecological, urological and other diseases. The objective of the invention is higher efficiency of the resin-free naftalan production method, lower adsorbent consumption, higher yield of active naphthene hydrocarbons, environment improvement, and utilisation, among others, of naftalan oil wastes. The objective is achieved by a method wherein crude naftalan oil heated to 150°C is subjected to diffusion distillation under vacuum by passing dry steam heated to 230°C, followed by adsorption cleaning of the produced 190-220°C naphthene fraction by silica gel, with the ratio of the naphthene fraction to the adsorbent of 1:0.12 by weight, at a cleaning temperature of 60°C.